Cardiopulmonary morbidity and quality of life in non-small cell lung cancer patients treated with or without postoperative radiotherapy

Radiotherapy and Oncology

Volumn 98, Issue 2, 2011, Pages 238-243

  Kepka, Lucyna ^a   Bujko, Krzysztof ^a   Orlowski, Tadeusz M ^b   Jagiello, Robert ^b   Salata, Andrzej ^c   Matecka Nowak, Miroslawa ^d   Janowski, Henryk ^e   Rogowska, Danuta ^f  

^a INSTITUTE OF ONCOLOGY   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^c Holycross Cancer Center   (Poland)

^d GREATER POLAND CANCER CENTRE   (Poland)

^e Regional Hospital for Lung Diseases   (Poland)

^f POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Cardiopulmonary morbidity; Non small cell lung cancer; Postoperative radiotherapy; Pulmonary function tests; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CARDIOPULMONARY FUNCTION; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HEART; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 79951855591     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.09.020     Document Type: Article

References (27)

1. PORT Meta-analysis Trialists Group Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomized controlled trials Lancet 352 1998 257 263
2. PORT Meta-analysis Trialists Group Postoperative radiotherapy for non-small-cell lung cancer Cochrane Database Syst Rev 2005 2 [Art.No:CD002142.pub2]
3. L. Trodella, P. Granone, and S. Valente Adjuvant radiotherapy in non-small cell lung cancer with pathological stag (Pubitemid 34121945)
4. M. Machtay, L. Kaiser, and E. Glatstein Is meta-analysis really meta-physics? Chest 116 1999 539 542 (Pubitemid 29382141)
5. J.A. Bonner The role of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma: seeking to optimize local control and survival while minimizing toxicity Cancer 86 1999 195 196 (Pubitemid 29327574)
6. Thames HD. Postoperative radiotherapy of non-small cell lung cancer: a flow in the PORT meta-analysis. In: Kogelnik HD, Lukas P, Sedlemayer F, editors. Progress in Radiotherapy VII, Monduzzi Editore, Bologna, 2002; 9-16.
7. B. Dautzenberg, R. Arriagada, and A. Boyer-Chammard A controlled study of postoperative radiotherapy for patients with completely resected non-small-cell lung carcinoma Cancer 86 1999 265 273 (Pubitemid 29327583)
8. J. Jassem The role of radiotherapy in lung cancer: Where is the evidence? Radiother Oncol 83 2007 203 213 (Pubitemid 46776921)
9. M. Baumann, D. Zips, and S. Appold Radiotherapy of lung cancer: Technology meets biology meets multidisciplinarity Radiother Oncol 91 2009 279 281
10. P. Phlips, P. Rocmans, and P. Vanderhoeft Postoperative radiotherapy after pneumonectomy: impact of modern treatment facilities Int J Radiat Oncol Biol Phys 20 1991 525 529 (Pubitemid 23331117)
11. H.A. Wakelee, P. Stephenson, and S.M. Keller Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590 Lung Cancer 48 2005 389 397 (Pubitemid 40693625)
12. M. Machtay, J.H. Lee, and J.B. Shrager Risk of death from intercurrent disease is not excessively increased by modern postoperative radiotherapy for high-risk resected non-small cell lung cancer J Clin Oncol 19 2001 3912 3917 (Pubitemid 32912018)
13. B.E. Lally, D. Zelterman, and J.M. Calasanto Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end-results database J Clin Oncol 24 2006 2998 3006 (Pubitemid 46638932)
14. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 2008 3552 3559
15. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLO-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376 (Pubitemid 23073154)
16. J.J. Pavy, J. Denekamp, and J. Letschert EORTC late effects working group. Late effects toxicity scoring: the SOMA scale Radiother Oncol 35 1995 11 15
17. LENT SOMA tables Radiother Oncol 35 1995 17 60
18. C.F. Mountain, and C.M. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723 (Pubitemid 27260108)
19. G.R. Borst, K. de Jaeger, J.S.A. Belderbos, S.A. Burgers, and J.V. Lebesque Pulmonary function changes after radiotherapy in non-small cell lung cancer patients with long-term disease-free survival Int J Radiat Oncol Biol Phys 62 2005 639 644 (Pubitemid 40779748)
20. V. Mehta Radiation pneumonitis and pulmonary fibrosis in non-small cell lung cancer: pulmonary function, prediction, and prevention Int J Radiat Oncol Biol Phys 63 2005 5 24 (Pubitemid 41583538)
21. S. Miyoshi, T. Yoshimasu, and T. Hirai Exercise capacity of thoracotomy patients in the early postoperative period Chest 118 2000 384 390 (Pubitemid 30637804)
22. L.B. Marks, S.M. Bentzen, and J.O. Deasy Radiation dose-volume effects in the lung Int J Radiat Oncol Biol Phys 76 2010 S70 S76
23. R. Rami-Porta, C. Wittekind, and P. Goldstraw International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: proposed definition Lung Cancer 49 2005 25 33
24. R. Mayer, F.M. Smolle-Juetner, and D. Szolar Postoperative radiotherapy in radically resected non-small-cell lung cancer Chest 112 1997 951 959
25. E.F. Miles, C.R. Kelsey, J.P. Kirkpatrick, and L.B. Marks Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small cell lung cancer: calculations from clinical trials Int J Radiat Oncol Biol Phys 68 2007 1047 1052 (Pubitemid 47048582)
26. www.rtog.org. RTOG 94-10 trial. Electronic citation.
27. S.J. De Kort, P.H. Willemse, and J.M. Habraken Quality of life versus prolongation of life in patients treated with chemotherapy in advanced colorectal cancer: a review of randomized controlled clinical trials Eur J Cancer 42 2006 835 845 (Pubitemid 44294519)